14-1190b-innovation-managing-risk-evidence

168
27. Bickerstaffe, K. & Walker, G. Public
understanding of air pollution: the ‘localisation’
of environmental risk. Global Environmental
Change 11(2), 133-145 (2001)
28. Niemeyer, S., Petts, J. & Hobson, K. Rapid
climate change and society; assessing
responses and thresholds. Risk Analysis 26(6),
1443-1456, 2005
29. Siegrist, M. & Gutscher, H. Flooding risks: a
comparison of lay people’s perceptions and
experts’ assessments in Switzerland. Risk
Analysis 26(4), 971-79 (2006)
30. Petts, J. Health, responsibility, and choice:
contrasting negotiations of air pollution and
immunisation information. Environment and
Planning A. 37, 791-804 (2005)
31. Roco, M.C. Possibilities for global governace of
converging technologies. Journal of Nanoparticle
Research 10, 11-29 (2008)
32. Owen, R., Stilgoe, J., Macnaghten, P., Gorman,
M., Fischer, E & Guston, D. A Framework
for Responsible Innovation. In: Responsible
Innovation: Managing the Responsible Emergence
of Science and Innovation in Society, R. Owen,
J. Bessant & M. Heintz (eds), pp. 27-50 (John
Wiley & Sons, Chichester, 2013)
33. Lee, R.G. & Petts, J. Adaptive Governance
for Responsible Innovation. In: Responsible
Innovation: Managing the Responsible Emergence
of Science and Innovation in Society, R. Owen, J.
Bessant & M. Heintz (eds), pp. 143-164 (John
Wiley & Sons, Chichester, 2013)
34. Royal Commission on Environmental Pollution
Novel Materials in the Environment: The Case of
Nanotechnology. 27 th Report. (The Stationary
Office, London, 2008)
35. Guston, D. & Sarewitz, D. Real-time technology
assessment. Technology in Society 24(1-2), 93-
109, 2002.
36. Sykes, K & Macnaghten, P. Responsible
Innovation – Opening up Dialog and
Debate. In: Responsible Innovation: Managing
the Responsible Emergence of Science and
Innovation in Society, R. Owen, J. Bessant & M.
Heintz (eds), pp. 85-107 (John Wiley & Sons,
Chichester, 2013)
37. Bull, R; Petts, J. & Evans, J. The importance
of context for effective public engagement:
learning from the governance of waste. Journal
of Environmental Planning and Management
53(8), 991-1010 (2010)
38. Murdock, G., Petts, J. & Horlick-Jones, T.
After amplification: rethinking the role of
the media in risk communication. In: The
Social Amplification of Risk , N, Pidgeon, R.E.
Kasperson & P. Slovic (eds); pp. 156-178.
(Cambridge University Press, Cambridge,
2003)
Chapter 9 Case Study: MMR, Bowel Disease,
Autism and Measles
1. Wakefield AJ, Pittilo RM, Sim R. Evidence of
persistent measles virus infection in Crohn’s
disease. J Med Virol 39:345–353, 1993.
2. Farrington P, Miller E. Measles vaccination as
a risk factor for inflammatory bowel disease.
Lancet 345:1362, 1995.
3. Feeney M, Ciegg A, Winwood P, Snook J. A
case control study of measles vaccination and
inflammatory bowel disease. Lancet 350:764–
766, 1997
4. Wakefield A, Murch SH, Anthony A, et al. Ileallymphoid-nodular
hyperplasia, non-specific
colitis, and pervasive developmental disorder
in children. Lancet 351:637–641, 1998.
5. Chadwick N, Bruce IJ, Schepelmann S, et
al. Measles virus RNA is not detected in
inflammatory bowel disease using hybrid
capture and reverse transcription followed
by the polymerase chain reaction. J Med Virol
55:305–311, 1998.
6. Cedillo & Cedillo vs. Secretary of Health and
Human Services, No. 98-916V, 57-58 (United
States Court of Federal Claims, 2009): http://
www.autism-watch.org/omnibus/cedillo.pdf
7. Taylor B, Miller E, Farrington CP, et al.
Autism and measles, mumps and rubella:
no epidemiological evidence for a causal
association. Lancet 353:2026–2029, 1999.
8. Fombonne E, Chakrabarti S. No evidence
for a new variant of measles-mumps-rubellainduced
autism. Pediatrics 108(suppl 4):E58,
2001.
9. Medical Research Council. MRC Review of
Autism Research: Epidemiology and Causes.
London, Medical Research Council, 2001.
Online. Available at: http://www.mrc.ac.uk/pdfautism-report.pdf.
10. Dales L, Hammer SJ, Smith NJ. Time trends in
autism and in MMR immunization coverage in
California. JAMA 285:1183–1185, 2001.
11. Farrington CP, Miller E, Taylor B. MMR and
autism: further evidence against a causal
association. Vaccine 19:3632–3665, 2001.
12. Taylor B, Miller E, Lingam R, et al. Measles,
mumps, and rubella vaccination and bowel
problems or developmental regression in
children with autism: population study. BMJ
324:393–396, 2002.
13. Madsen KM, Hviid A, Vestergaard M, et al. A
population-based study of measles, mumps,
and rubella vaccination and autism. N Engl J
Med 347:1477–1482, 2002.
14. Smeeth L, Cook C, Fombonne E, et al. MMR
vaccination and pervasive developmental
disorders: a case-control study. Lancet 364
(9438):963–9, 2004.
15. Ramsay ME, Yarwood J, Lewis D, et al. Parental
confidence in measles, mumps, and rubella
vaccine: evidence from vaccine coverage and
attitudinal surveys. Br J Gen Pract 52:912–916,
2002.
16. Effects of media reporting on MMR coverage.
Commun Dis Rep CDR Wkly 12(35):30, 2002.
17. Tracking mothers attitudes to childhood
immunisation 1991-2001. Yarwood J, Noakes
K, Kennedy D, Campbell H, Salisbury D M.
Vaccine 2005;23(48049):5670-87.
18. Drop in MMR jabs blamed on media
scare (1998): http://news.bbc.co.uk/1/hi/
health/120277.stm
19. Mason,BW and Donnelly PD Impact of a
local newspaper campaign on the uptake of
the measles mumps and rubella vaccine J
Epidemiol Community Health 2000;54:473-
474 doi:10.1136/jech.54.6.473
20. NHS Immunisation Statistics England 2012–13:
https://catalogue.ic.nhs.uk/publications/
public-health/immunisation/nhs-immu-stat-
eng-2012-2013/nhs-immu-stat-eng-2012-13-
rep.pdf
21. Ramsay ME et al. The Elimination of Indigenous
Measles Transmission in England and Wales
J. Infect. Dis. 2003; 187 (Supplement 1):
S198-S207. doi: 10.1086/368024
22. MMR doctor struck from register (2010):
http://news.bbc.co.uk/1/hi/health/8695267.stm
Chapter 10: Managing Existential Risk from
Emerging Technologies
1. Beckstead, Nick et. al. (2014). “Unprecedented
Technological Risks,” Working paper. Oxford
University, Future of Humanity Institute.
2. Office for National Statistics. (2012).
“Mortality in England and Wales: Average
lifespan, 2010.” Available online at http://www.
ons.gov.uk/ons/rel/mortality-ageing/mortalityin-england-and-wales/average-life-span/rptaverage-life-span.html
3. Matheny, Jason G. (2007) “Reducing the risk of
human extinction.” Risk analysis 27, 1335-1344,
p. 1336.
4. For more detail, see Bostrom, Nick, and Milan
M. Cirkovic, eds. (2008). Global catastrophic
risks. Oxford University Press.
5. Jackson, Ronald J., et al. (2001). “Expression
of mouse interleukin-4 by a recombinant
ectromelia virus suppresses cytolytic
lymphocyte responses and overcomes genetic
resistance to mousepox.” Journal of Virology 75:
1205-1210;
Nowak, R. “Disaster in the making.” New
Scientist; January 13, 2001.
Ramshaw, I. XIII International Poxvirus and
Iridovirus Symposium, Montpellier, France;
September 2000.
6. Buller, R.M.L. Smallpox BioSecurity: Preventing
the Unthinkable, Geneva, Switzerland; October
21–22, 2003.
7. Imai, M. et al. “Experimental Adaptation of an
Influenza H5 HA Confers Respiratory Droplet
Transmission to a Reassortant H5 HA /H1N1
Virus in Ferrets,” Nature 486, 420–428; June
21, 2012.
8. Fouchier, Ron et al. (2013). “Avian flu: Gainof-function
experiments on H7N9.” Nature
500,150–151.
9. Lipsitch M, Galvani AP. (2014). “Ethical
Alternatives to Experiments with Novel
Potential Pandemic Pathogens.” PLoS Med
11(5): e1001646.
10. Church, George. (2004). A synthetic biohazard
non-proliferation proposal, Cambridge, MA:
Havard University. URL: http://arep.med.
harvard.edu/SBP/Church_Biohazard04c.htm.
11. Posner, Richard. (2004). Catastrophe: Risk
and Response. p. 5. (Oxford University Press,
Oxford).
12. Myhrvold, Nathan. (2013). “Strategic Terrorism:
A Call to Action,” in the Lawfare research
paper series.
13. Rees, Martin. (2003). Our Final Century.
(Heinemann, London).
14. Ibid. p. 48.
15. For example, variants of a framework called
AIXI have learned how to play a variety of off
the shelf computer games just from access
to a video stream of the computer screen
and trial and error. Bellemare, Marc et al.
(2013). “The Arcade Learning Environment: an
evaluation platform for general agents.” Journal
of Artificial Intelligence Research 47:253–79.
16. For the most detailed discussion of this
set of issues, see Bostrom, Nick. (2014).
Superintelligence: Paths, Dangers, Strategies.
Oxford University Press. For related
arguments, also see: